FDA approves first non-opioid to treat withdrawal symptoms in adults
The opioid addiction market got a new player Wednesday with the FDA approval of Lucemyra, a pill that helps patients manage symptoms of withdrawal.
The drug, which has been used in the United Kingdom for more than two decades now, is made by Louisville, KY-based US WorldMeds. The specialty pharma was not granted approval to treat opioid use disorder, but instead to treat symptoms of withdrawal.
For those addicted to opioids, quitting cold turkey can be a harrowing experience. In as little as a few hours, patients may experience stomach cramps, muscle aches and spasms, a pounding heart, nausea, vomiting and diarrhea. Other symptoms include anxiety, agitation, depression and insomnia.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.